Speaker: Andrés Enrique Gustavo Ruuth, Scientific Coordinator, IMiBio, Misiones, Argentina
Erik Ruuth, M.D., PH.D., Ass. Prof. is a medical doctor with a Ph.D. in immunology and an adjunct professor in cell and molecular biology at Umeå University.
After completing a postdoc at Hôpital Necker Enfants Malades in Paris, France, Erik made a career within the pharmaceutical industry covering areas ranging from basic industrial research to the molecular activities of new active principles, discoveries of mechanisms of action, preclinical development phases, clinical studies for registry, for authorities such as the FDA and EMA, ranging from PhI to III and post-marketing studies (PhIV). He assumed a number of responsibilities, as head of global research projects, head of EU therapeutic areas for anti-infectives, respiratory system and central nervous system products, head of development programs, expert in global products, project leader global research leader and leader of different types from PhI to PhIII clinical trials. As a consultant, ER has worked for the Ministry of Science and Technology of Argentina, for the National Cancer Institute in a large breast cancer project, consultant for the pharmaceutical and biotechnology industry. He is currently senior scientific advisor at the Madariaga Hospital in Posadas (Misiones), Principal Investigator at the Faculty of Medicine of the Catholic University of Misiones and Scientific Coordinator of the Misiones Institute for Biodiversity.